|
시장보고서
상품코드
2055335
방사선 종양학 시장 : 치료 유형별, 기술별, 용도별, 최종 사용자별, 지역별Radiation Oncology Market, By Therapy Type, By Technology, By Application, By End User, By Geography |
||||||
방사선 종양학 시장은 2026년에 139억 4,000만 달러에 달하고 2033년까지 296억 7,000만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR은 11.4%를 나타낼 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 시장 규모(2026년) : | 139억 4,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 11.40% | 시장 규모 예측(2033년) : | 296억 7,000만 달러 |
세계 방사선 종양학 시장은 의료 업계의 중요한 분야로, 정밀한 방사선 조사 시스템을 통해 암을 치료하기 위해 설계된 첨단 의료 기술 및 치료 솔루션을 포괄합니다. 방사선 종양학은 의학의 전문 분야로서, 고에너지 방사선 빔을 이용해 악성 세포를 파괴하는 동시에 주변 정상 조직에 대한 손상을 최소화하기 때문에 종합적인 암 치료 프로토콜에서 필수적인 요소로 자리 잡고 있습니다. 이 시장에는 리니어 가속기, 근접 치료기, 양성자 치료 시스템, 정위 방사선 수술 장치와 같은 다양한 첨단 장비뿐만 아니라, 치료 계획 및 환자 관리를 위한 지원 소프트웨어 솔루션도 포함됩니다.
고령화, 생활 습관의 변화, 환경적 요인으로 인해 전 세계적으로 암의 부담이 증가함에 따라, 방사선 종양학은 현대 암 의료의 기반으로서 그 위상을 확고히 하고 있습니다. 전 세계의 의료 기관들은 치료의 정확도를 높이고, 부작용을 줄이며, 환자의 예후를 개선하기 위해 최첨단 방사선 치료 장비에 막대한 투자를 하고 있습니다. 이 시장의 발전은 영상 유도 방사선 치료(IGRT), 강도조절 방사선 치료(IMRT), 인공지능(AI)의 통합 등 지속적인 기술적 진보로 특징지어집니다. 이러한 요소들은 종합적으로 볼 때, 보다 개인 맞춤형의 효과적인 암 치료 접근법에 기여하고 있으며, 방사선 종양학을 세계 의료 분야에서 필수불가결하고 급속히 성장하는 분야로 자리매김하게 하고 있습니다.
시장 역학
세계 방사선 종양학 시장은 견조한 성장세를 뒷받침하는 몇 가지 강력한 시장 성장 촉진요인에 힘입어 성장하고 있습니다. 그 주된 원인은 전 세계 암 발병률 증가에 있으며, 이에 따라 고도의 치료적 개입이 필요해짐에 따라 전 세계 의료시설에서 첨단 방사선 치료 기기에 대한 수요가 크게 증가하고 있습니다. 세계적인 고령화 또한 중요한 인구학적 요인으로 작용하고 있습니다. 암 유병률은 나이가 들수록 크게 증가하기 때문에 병원이나 전문 암 치료 센터에서 방사선 종양학 서비스 및 장비 업그레이드에 대한 지속적인 수요가 발생하고 있습니다. 기술 혁신 또한 중요한 성장 요인 중 하나입니다. 정밀의료, 인공지능(AI) 통합, 영상 유도 방사선 치료, 양성자 치료 분야의 획기적인 발전은 치료 효과를 높이는 동시에 부작용을 경감시키고 있으며, 이에 따라 의료 기관들은 차세대 방사선 종양학 솔루션에 대한 투자를 확대되고 있습니다.
그러나 시장에는 뚜렷한 제약도 존재합니다. 특히 첨단 방사선 치료 장비의 도입 및 설치에 따르는 막대한 자본 비용은 의료 예산을 압박하여, 특히 신흥 시장이나 소규모 의료시설에서 도입률을 제한하는 요인이 될 수 있습니다. 게다가, 자격을 갖춘 방사선종양전문의, 의료물리사 및 훈련을 받은 기술자의 부족은 시장 확장을 저해하는 운영상의 제약을 초래하고 있습니다. 또한, 새로운 방사선 치료 기술에 대한 엄격한 규제 승인 절차는 제품 출시 및 시장 침투를 지연시킬 수 있습니다. 이러한 과제가 있음에도 불구하고, 개발도상국의 의료 인프라 확충, 암 치료 개선을 위한 정부 주도의 노력 증가, 첨단 암 치료를 추구하는 의료 관광의 확대, 그리고 치료 효율과 환자 편의성을 높이는 소분할 방사선 치료법의 도입 확대와 같은 요인들로 인해 큰 기회가 창출되고 있습니다. 이로 인해 방사선 종양학 시장은 지속적인 장기 성장 궤도에 올랐습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 지표를 바탕으로 세계 방사선 종양학 시장의 주요 기업 프로파일을 작성했습니다. 기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 기종 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 방사선 종양학 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있게 됩니다.
목차
제1장 조사 목적 및 전제 조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 방사선 종양학 시장 : 치료 유형별(2021-2033년)
제5장 세계의 방사선 종양학 시장 : 기술별(2021-2033년)
제6장 세계의 방사선 종양학 시장 : 용도별(2021-2033년)
제7장 세계의 방사선 종양학 시장 : 최종 사용자별(2021-2033년)
제8장 세계의 방사선 종양학 시장 : 지역별(2021-2033년)
제9장 경쟁 구도
제10장 애널리스트의 제안
제11장 참고 문헌 및 조사 방법
KTH 26.06.19Radiation Oncology Market is estimated to be valued at USD 13.94 Bn in 2026 and is expected to reach USD 29.67 Bn by 2033, growing at a compound annual growth rate (CAGR) of 11.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 13.94 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 11.40% | 2033 Value Projection: | USD 29.67 Bn |
The global radiation oncology market represents a critical segment of the healthcare industry, encompassing advanced medical technologies and therapeutic solutions designed to combat cancer through precise radiation delivery systems. Radiation oncology, as a specialized field of medicine, utilizes high-energy radiation beams to destroy malignant cells while minimizing damage to surrounding healthy tissues, making it an indispensable component of comprehensive cancer treatment protocols. This market encompasses a diverse array of sophisticated equipment including linear accelerators, brachytherapy devices, proton therapy systems, and stereotactic radiosurgery units, alongside supporting software solutions for treatment planning and patient management.
The increasing global cancer burden, driven by aging populations, lifestyle changes, and environmental factors, has positioned radiation oncology as a cornerstone of modern oncological care. Healthcare institutions worldwide are investing substantially in state-of-the-art radiation therapy equipment to enhance treatment precision, reduce side effects, and improve patient outcomes. The market's evolution is characterized by continuous technological advancements, including image-guided radiation therapy (IGRT), intensity-modulated radiation therapy (IMRT), and artificial intelligence integration, which collectively contribute to more personalized and effective cancer treatment approaches, establishing radiation oncology as an essential and rapidly expanding segment within the global healthcare landscape.
Market Dynamics
The global radiation oncology market is propelled by several compelling drivers that collectively fuel its robust growth trajectory, primarily anchored by the escalating global cancer incidence rates, which necessitate advanced therapeutic interventions and drive substantial demand for sophisticated radiation therapy equipment across healthcare facilities worldwide. The aging global population presents a significant demographic driver, as cancer prevalence increases substantially with age, creating sustained demand for radiation oncology services and equipment upgrades in hospitals and specialized cancer treatment centers. Technological innovations serve as another pivotal growth driver, with breakthrough developments in precision medicine, artificial intelligence integration, image-guided radiation therapy, and proton beam therapy enhancing treatment efficacy while reducing adverse effects, thereby encouraging healthcare institutions to invest in next-generation radiation oncology solutions.
However, the market faces notable restraints including the exceptionally high capital costs associated with acquiring and installing advanced radiation therapy equipment, which can strain healthcare budgets and limit adoption rates, particularly in emerging markets and smaller healthcare facilities. Additionally, the shortage of qualified radiation oncologists, medical physicists, and trained technicians creates operational constraints that can impede market expansion, while stringent regulatory approval processes for new radiation therapy technologies can delay product launches and market penetration. Despite these challenges, significant opportunities emerge from the expanding healthcare infrastructure in developing nations, increasing government initiatives for cancer care improvement, growing medical tourism for advanced cancer treatments, and the rising adoption of hypofractionated radiation therapy techniques that improve treatment efficiency and patient convenience, positioning the radiation oncology market for sustained long-term growth.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global radiation oncology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Varian Medical Systems Inc., Elekta AB, Accuray Incorporated, Mevion Medical Systems, ViewRay Technologies Inc., Isoray Inc., Hitachi Ltd., IBA (Ion Beam Applications SA), Nordion Inc., Brainlab SE, Xstrahl Ltd., Panacea Medical Technologies Pvt. Ltd., Siemens Healthineers AG, GE HealthCare, and Bionix Radiation Therapy LLC.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global radiation oncology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global radiation oncology market
Market Segmentation
- Therapy Type Insights (Revenue, USD Bn, 2021 - 2033)
- External Beam Radiation Therapy (EBRT)
- Internal Beam Radiation Therapy (Brachytherapy/Internal)
- Proton and Heavy Ion Therapy
- Radiopharmaceutical and Systemic Radiation Therapy
- Technology Insights (Revenue, USD Bn, 2021 - 2033)
- 3D Conformal Radiotherapy (3D CRT)
- Intensity Modulated Radiotherapy (IMRT)
- Volumetric Modulated Arc Therapy (VMAT)
- Image Guided Radiotherapy (IGRT)
- Stereotactic Radiotherapy (SRS/SBRT)
- High Dose Rate (HDR)/Low Dose Rate (LDR) Brachytherapy
- Adaptive Radiotherapy/Real Time Tumor Tracking
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Head and Neck Cancer
- Colorectal Cancer
- Gynecologic Cancers
- Other Cancers (e.g., skin, brain, pancreas, rare tumors)
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals (Cancer/Radiation Therapy Departments)
- Dedicated Oncology and Radiotherapy Centers
- Ambulatory/Outpatient Radiotherapy Clinics
- Research and University Institutes
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Varian Medical Systems Inc.
- Elekta AB
- Accuray Incorporated
- Mevion Medical Systems
- ViewRay Technologies Inc.
- Isoray Inc.
- Hitachi Ltd.
- IBA (Ion Beam Applications SA)
- Nordion Inc.
- Brainlab SE
- Xstrahl Ltd.
- Panacea Medical Technologies Pvt. Ltd.
- Siemens Healthineers AG
- GE HealthCare
- Bionix Radiation Therapy LLC
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Radiation Oncology Market, By Therapy Type
- Global Radiation Oncology Market, By Technology
- Global Radiation Oncology Market, By Application
- Global Radiation Oncology Market, By End User
- Global Radiation Oncology Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Radiation Oncology Market, By Therapy Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- External Beam Radiation Therapy (EBRT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Internal Beam Radiation Therapy (Brachytherapy/Internal)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Proton and Heavy Ion Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Radiopharmaceutical and Systemic Radiation Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Radiation Oncology Market, By Technology, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- 3D Conformal Radiotherapy (3D CRT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Intensity Modulated Radiotherapy (IMRT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Volumetric Modulated Arc Therapy (VMAT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Image Guided Radiotherapy (IGRT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Stereotactic Radiotherapy (SRS/SBRT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- High Dose Rate (HDR)/Low Dose Rate (LDR) Brachytherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Adaptive Radiotherapy/Real Time Tumor Tracking
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Radiation Oncology Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Head and Neck Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Colorectal Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Gynecologic Cancers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other Cancers (e.g., skin, brain, pancreas, rare tumors)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Radiation Oncology Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals (Cancer/Radiation Therapy Departments)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Dedicated Oncology and Radiotherapy Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ambulatory/Outpatient Radiotherapy Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Research and University Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Radiation Oncology Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Varian Medical Systems Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Elekta AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Accuray Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mevion Medical Systems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ViewRay Technologies Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Isoray Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hitachi Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- IBA (Ion Beam Applications SA)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nordion Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Brainlab SE
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Xstrahl Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Panacea Medical Technologies Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GE HealthCare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bionix Radiation Therapy LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
